0.82
-0.035(-4.07%)
Currency In USD
Address
120 Presidential Way
Woburn, MA 01801
United States of America
Phone
781 245 1325
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
92
First IPO Date
October 29, 2021
| Name | Title | Pay | Year Born |
| Hermann Luebbert | CEO, President & Chairman | 784,789 | 1956 |
| Eugene Frederick Leffler | Chief Financial Officer | 502,908 | 1984 |
| Daniel Hakansson | Senior Corporate Counsel | 0 | N/A |
| George Jones | Chief Commercial Officer | 0 | N/A |
| Jon Lyons | Vice President of Scientific & Medical Affairs | 0 | N/A |
| Erica F. Gates | Senior Director of Finance & Principal Accounting Officer | 0 | N/A |
| Samantha Widdicombe | Senior Vice President of Sales & Marketing | 0 | N/A |
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
